New Horizons for the Treatment of Cardiomyopathy in Children
Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
Collecting mono nuclear cells from the patient's blood after a course of granulocyte
stimulation then injecting them into the weak heart muscle measuring the heart function at
the beginning and after 2.4.6 months to assess the improvement due to this procedure, by
comparing these patients to patients with the same condition treated the classic way.